HVC
ALKS icon

Healthcare Value Capital’s Alkermes ALKS Stock Holding History

Healthcare Value Capital’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$3.08M Sell
100,000
-50,000
-33% -$1.41M 6.09% 4
2021
Q2 		$3.68M Buy
150,000
+50,000
+50% +$1.11M 7.33% 4
2021
Q1 		$1.87M Buy
+100,000
New +$2.05M 4.16% 12

Other funds holding ALKS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.85B AUM 35.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Healthcare Value Capital's ALKS Position: Q3 2021 in Review

Healthcare Value Capital reduced its Alkermes (ALKS) stake by 33% in Q3 2021, selling an estimated $1.41M and leaving 100,000 shares worth $3.08M. The position accounts for 6.09% of the portfolio, ranked #4.

Healthcare Value Capital first reported a position in ALKS in Q1 2021 and has held it in 3 quarters since. The position peaked at $3.68M in Q2 2021. 224 funds tracked by Wall St. Rank hold ALKS as of Q3 2021.

  • Healthcare Value Capital held 100,000 shares of Alkermes worth $3.08M as of Q3 2021.
  • Healthcare Value Capital sold 50,000 Alkermes shares in Q3 2021, an estimated $1.41M.
  • Alkermes made up 6.09% of Healthcare Value Capital's portfolio in Q3 2021, its #4 holding.
  • Healthcare Value Capital first reported a position in Alkermes in Q1 2021 and has held it in 3 quarters since.
  • Healthcare Value Capital's Alkermes position peaked at $3.68M in Q2 2021.
  • 224 funds tracked by Wall St. Rank held Alkermes as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.